Expand your
neurological assesment.

neuroClues® is a safe and effective CE-marked Class IIa medical device and the company operates under an ISO 13485:2016–certified quality management system. In addition, the company is ISO 27001:2022 certified for information security, ensuring the protection of patient and hospital data. neuroClues is GDPR-compliant and relies on EU-based providers for secure data storage of EU customers.

The exam takes approximately 10 minutes and can be delegated to an assistant or nurse. neuroClues supports you throughout the implementation process to ensure seamless integration into your practice and proper training of you and your team.

In several countries, including France and Belgium, electro-oculography is covered under existing procedure codes and can be integrated into outpatient clinic procedures. Reimbursement amounts for the procedure vary by country.

neuroClues® is a measurement device designed to record, visualize, and analyze eye movements to support the identification of visual tracking impairments in individuals aged 5 years and older.  The identification of eye movement impairments can help clinicians to confirm diagnosis, monitor disease progression, and in the future identify individuals at risk for various neurological disorders. Oculomotor abnormalities are hallmark features of cerebellar impairment and identified by clinical guidelines as red flags for aytpical parkinsonism.